Industry landscapes
Industry report

Funding and advertised pay are reported in USD; filed accounts retain their stated source currency and basis.

Exchange-rate basis

Indicative conversions use ECB reference rates dated 2026-09-14, applied consistently across all periods. They are not historical exchange rates. Indian rupees may use crore (1 crore = 10 million); other currencies use K, M and B. CSV downloads, source documents and quoted news headlines retain their original currencies.

THE ITALY EDITION 2026

Italy’s
life sciences industry,
in focus.

The companies, capital and talent shaping life sciences in Italy. Find the leaders. Understand the segments. See where the activity is.

Snapshot: Funding in USD
Illustrated cover for Life Sciences Industry Landscape of Italy
IT
COMPANIES · CAPITAL · TALENT

An industry ecosystem,
measured in context.

Life Sciences illustration
MEET THE COMPANIES

Explore Italy’s life sciences leaders

24 featured companies from the funding, hiring, revenue and team-size leaderboards.

Expand panel +
Life Sciences company highlights in Italy, snapshot 1 September 2026
Company
Medical Microinstrumentsmmimicro.com$209.5M—160—
AAVantgarde Bioaavantgarde.com$206.17M———
Kedrionkedrion.com$188.56M—5,000—
BioXellbioxell.com$88.01M———
Innovheartinnovheart.com$78.73M—32—
Genespiregenespire.com$69.34M—10—
Genenta Sciencegenenta.com$55.48M—9—
Entheraentherapharmaceuticals.com$45.91M—15—
Empaticaempatica.com—4 roles133—
Bioscience Institutebioinst.com—3 roles——
Nimble Roboticsnimblerobotics.com—3 roles——
Lyoconlyocon.com—2 roles——
Tensivetensivemed.com—2 roles18—
tema sinergietemasinergie.it—2 roles200—
Arsenale BioYardsarsenale.bio—1 roles——
DICEtechdicetech.ai—1 roles——
AAVantgarde Bioaavantgardebio.com——4—
Amplifonamplifon.com——375—
Diatech Pharmacogeneticsdiatechpharmacogenetics.com——60—
EOSeosmilano.com————
Exolab Italiaexolabitalia.com——9—
Farmaceutici Damorfarmadamor.it——196—
Newron Pharmaceuticalsnewron.com——23Financial figure available in RadarView in Radar
ab medicaabmedica.it——326—
24 featured companies

Locked revenue figures are available in Radar; the eight company financial previews stay the same throughout this page. A dash means the figure is outside these featured lists. Revenue years vary by company; the figures are not a like-for-like revenue comparison. Compare annual accounts ↗

Company discovery

Recorded evidence only

Explore the live startup set in Radar

No company example met every recorded classification, independence and public-profile gate in this snapshot. The live directory may have newer qualifying companies.

Explore classified startups in Radar ↗
THE KEY SIGNALS

Life Sciences industry KPIs in Italy

A few useful ratios bring the size of this ecosystem into perspective.

1 September 2026
Hiring participation3.4%

25 of 736 tracked companies have open roles.

Funding participation22.7%

167 of 736 tracked companies have a recorded round.

Top 3 funding share37.2%

Share of disclosed capital received by the three largest recorded recipients.

Median disclosed round$391.05K

Midpoint of 265 rounds with a disclosed amount.

Scale is concentrated. Opportunity is broader. The three largest funding recipients hold 37.2% of disclosed capital, while 77.3% of tracked companies have no recorded funding round.

Explore the segments →
CAPITAL & COMPANY FORMATION

How Italy life sciences has grown

Recorded company formation and disclosed funding across the complete annual series shown.

Expand panel +
2016 — 2025

Disclosed funding by year

Sum of recorded funding rounds · USD

Italy life sciences
$0$71.22M$142.43M$213.65M$284.87M2016: $33.52M20162017: $39.02M20172018: $118.79M20182019: $29.97M20192020: $97.8M20202021: $49.46M20212022: $249.89M20222023: $181.63M20232024: $189.95M20242025: $246.41M2025
View the numbers
Annual life sciences funding and company formation in Italy
YearFunding (USD)FoundedRaising
2016$33.52M4020
2017$39.02M4322
2018$118.79M3031
2019$29.97M3930
2020$97.8M2424
2021$49.46M2323
2022$249.89M1031
2023$181.63M1120
2024$189.95M29
2025$246.41M212
WHERE CAPITAL SITS

Funding concentration

Share of all disclosed company funding.

  • Medical Microinstruments12.9%
  • AAVantgarde Bio12.7%
  • Kedrion11.6%
  • Other companies62.8%

Funding by stage

306 recorded rounds since 2016

NUMBER OF ROUNDS
Seed & Angel61 19.9%
Series A–B51 16.7%
Series C+ / PE10 3.3%
Grants, debt & other184 60.1%

Recent recorded rounds

Latest recorded rounds · USD
2 rounds

Swipe or scroll horizontally to browse.

Series B05/2026
Cellply $8.36M

Backed by ENEA Tech e Biomedical and CDP Venture Capital.

Largest and notable recorded rounds

Each card is one recorded round
10 cards

Swipe or scroll horizontally to browse.

Series C01/2022
Innovheartinnovheart.com$55M

Backed by China Grand Pharmaceutical and Healthcare and Indaco Venture Partners and others.

THE BUSINESS BEHIND THE ACTIVITY

Revenue, profitability & financial strength

Expand panel +

Annual accounts availability

No reviewed exact national-ID connector has yet been qualified for Italy; this is a checked implementation boundary, not evidence that filings are absent.; No reviewed exact national-ID connector has yet been qualified for Italy; this is a checked implementation boundary, not evidence that filings are absent.

DIGITAL FOOTPRINT

Web traffic, app reach and release cadence

How the Italy companies on this page show up online: the sites people visit, the apps they install, and how often those apps ship.

Most-installed apps

31 of these companies (4.2%) publish at least one Android app — 71 apps in all, carrying 1.3M installs between them.

AppInstallsRatingStore category
AmplifonAmplifon601.9K3.5Medical
Amplifon AppAmplifon207.1K4.6Medical
MyNutrigeoProgeo156.3K—Health & Fitness
Alert for Embrace watchEmpatica47.7K3.3Medical
iSpirometryMedical International Research39.2K2.9Medical
MIR SPIROBANKMedical International Research33.9K3.8Medical
MIR SMART ONEMedical International Research28.6K3.5Health & Fitness
MyNutriversoProgeo27.9K—Health & Fitness
Mate for Embrace watchEmpatica21.1K2.9Health & Fitness
TurboLetturaOne Health Vision14.4K—Racing

Installs are lifetime totals to date at the June 2026 store reading — a measure of reach, not of people using an app today.

App reach by segment

The busiest app inside each of this page’s own segments, with the quarterly release trend behind it (2023Q2–2026Q1).

SegmentAppsInstallsLeading appRelease trend
Wearable Technology17927.5KAmplifon 601.9K
Assistive Tech6821.4KAmplifon App 207.1K
Ent Disorders3821.2KListen Responsibly 12.2K
Healthcare It19307.2KMyNutrigeo 156.3K
Nutraceuticals Tech4192KMyNutriverso 27.9K
Fitness & Wellness Tech3186.9KMyProgeoKeto 2.7K
Pulmonology7109.9KiSpirometry 39.2K
Disease Self Management13106.3KAlert for Embrace watch 47.7K

A company can carry several segment tags, so these rows overlap and should not be added together. Trend lines are zero-based and share one quarter grid, so a flat line is a quiet segment, not a missing one.

Release cadence by quarter

New apps published, beside apps whose most recent update landed in that quarter — the second bar is how much of the shelf is still being maintained.

2022Q4: 22022Q4: 02022Q42023Q2: 42023Q2: 32023Q22023Q3: 12023Q3: 12023Q32023Q4: 22023Q4: 02023Q42024Q1: 12024Q1: 22024Q12024Q2: 12024Q2: 22024Q22024Q3: 22024Q3: 32024Q32024Q4: 12024Q4: 02024Q42025Q1: 12025Q1: 32025Q12025Q3: 12025Q3: 62025Q32025Q4: 22025Q4: 132025Q42026Q1: 12026Q1: 182026Q1

Darker bars are new releases, lighter bars apps updated. 46 of 71 apps carry a release date. The series ends at 2026Q1, the last quarter that closed before the June 2026 reading.

INSIDE THE INDUSTRY

The Italy life sciences market map

Explore the segments behind the headline numbers.

Expand panel +

Where companies are building

Rank segments by scale, hiring or disclosed funding.

Enterprise tech451
Medical devices215
Healthtech116
Deep tech94
Biopharmaceuticals87
Consumer digital82
Enterprise software80
In vitro diagnostics32
Saas25
Nutritional formula22
Healthtech saas22
Iot in healthcare21

Companies can sit in several segments. Counts and funding overlap.

SEGMENT TO EXPLORE

Enterprise tech

The largest measured segment in this report snapshot.

451companies
3.5%have hiring activity

16 companies hiring · $1.5B disclosed funding

Explore in Radar

How companies make money

Common revenue models; a company can use more than one.

Physical commerce427
E-commerce - product352
Subscription164
Fee-for-service116
Commission on transaction26
Advertising22
E-commerce - service9
Sponsorship1
THE COMPANIES IN MOTION

Who is listing, hiring leaders, launching and winning work

Recorded corporate activity linked to companies in this landscape.

Expand panel +
Recent corporate headlines 10 dated reports
Mergers & acquisitionseosmilano.com ↗

EOS has acquired 100% of Metalpine GmbH, a Graz-based specialist in metal powders for additive manufacturing, completing a transition from minority shareholder to full owner.

Funding roundswearable-robotics.com ↗

Wearable Robotics, a start-up specialising in wearable robotics for neuromotor rehabilitation, has announced that it has secured a €5 million Series A funding round to accelerate its international expansion and bring its technologies to key global markets. The operation is led by CDP Venture Capital, through the Acceleratori Fund, with the participation of MITO Technology, through the Mito Tech Transfer Fund, Liftt, and Simest, using resources from the F.394/81 fund – Venture Capital and Equity Investment Section managed under an agreement with the Ministry of Foreign Affairs and International Cooperation, RoboIT (National Technology Transfer Hub for Robotics and Industrial Automation) and the Toscana Next co-investment fund, established and managed by CDP Venture Capital and subscribed to by the main banking foundations in Tuscany: Fondazione CR Firenze, Fondazione Cassa di Risparmio di Lucca, Fondazione Caript, Fondazione Monte dei Paschi di Siena, to maximise investment in innovative local businesses. The funds raised represent a crucial strategic step in supporting the company’s growth trajectory. In particular, the capital will be allocated to expanding the product portfolio and commercial development, with the aim of strengthening the company’s competitive position in key international markets.

Funding roundsgenogra.com ↗

GenoGra, a B2B start-up that is redefining the standards of genomic analysis, announces that it has closed a €1 million pre-seed investment round.

Funding roundsnewron.com ↗

Newron Pharmaceuticals S.p.A. entered into an agreement for the subscription of newly issued shares for proceeds of up to EUR 38 million with a group of existing and new shareholders from Europe and Asia, strengthening the Company’s financial position as it advances the ENIGMA-TRS Phase III program.

Mergers & acquisitionslyocon.com ↗

NUBURU, Inc. (NYSE American: BURU), a global pioneer in high-performance blue laser technology, today announced the completion of its acquisition of Lyocon S.r.l. (“Lyocon”).

Mergers & acquisitionsfreiafarmaceutici.it ↗

CleanGo's subsidiary Kubera will acquire Freia through a share exchange of up to 25 million shares, subject to due diligence and regulatory approvals within 45 days.

Funding roundsaavantgardebio.com ↗

AAVantgarde Bio, a Milan, Italy-based clinical-stage, biotechnology company ... raised $141M in Series B funding.

Funding roundsgenenta.com ↗

Genenta Science, a pioneer in the field of immuno-oncology listed on Nasdaq, announces that it has entered into a securities purchase agreement with institutional investors, US investment funds, for the purchase of 4,285,715 American Depositary Shares (ADS) at an offer price of $3.50 per ADS, for gross proceeds of approximately $15.0 million, gross of underwriting commissions and other estimated offering expenses.

Mergers & acquisitionsempatica.com ↗

Empatica has acquired PKG Health to enhance its AI-enabled wearable technology with validated movement disorder algorithms.

Mergers & acquisitionsaenduo.com ↗

SOL Spa, through its subsidiary AIRSOL Srl, has acquired an 80 percent stake in Aenduo Srl, a software company specializing in chronic disease management.

Full recorded event mix

Top 10 categories among 96 recorded events in the 24-month window.

Funding rounds
28
Mergers & acquisitions
18
Leadership moves
10
Company announcements
9
Capital infusions
8
Earnings
6
Asset acquisitions
6
Contracts
5
IPO activity
3
New products
3
3 activity cards

Swipe or scroll horizontally to browse.

Leadership moves

5 tracked people moves

Philip Lao

Appointment Senior Vice President of Business Development

EOS ↗
Jaime Gornsztejn

Appointment Responsible for corporate engagements in Latin America and Russia

EOS ↗
Björn Hannappel

Appointment Board Member

Torsten M. Madsen

Appointment CEO

Valerio Ferri

Appointment

Contract wins

2 recorded customer wins

Customer: Sòphia High TechAerospace and Defence

Kedrion ↗

Customer: biotestBiotechnology

Mergers and acquisitions

Company-linked deal reports; status is preserved as recorded.

Acquirer → targetStatusDateValue / context
EOS→metalpineAnnounced2026-04-21Not stated in snapshot
appviewx→EOS ↗Announced2026-03-19Not stated in snapshot
appviewx→EOS ↗Announced2026-03-19Not stated in snapshot
Newron Pharmaceuticals→Sabari Indian SchoolCompleted2026-01-29Not stated in snapshot
nuburu→Lyocon ↗Completed2026-01-20Not stated in snapshot
Kubera Black Technology Inc→Freia Farmaceutici ↗Announced2025-12-09Not stated in snapshot

A discussion or rumour is not a completed transaction. An unstated value is not zero.

PEOPLE & OPPORTUNITY

The talent market

Recorded hiring and workforce signals from the available source snapshot.

Expand panel +

Most advertised job titles

No repeated job title is supported by this snapshot.

0 internship postings

0 tracked postings mention remote work.

THE PEOPLE BUILDING THE FIELD

Founders and leaders

466 founders and chief executives across 326 companies.

Expand panel +
12 profiles

Swipe or scroll horizontally to browse.

Education networks

15 profiles with education records.

Bocconi University
3
Harvard University
3
INSEAD
2
National University of Singapore (NUS)
2
University of California (Berkeley)
1
Yale University
1
King’s College London
1
Imperial College London
1

Prior employers

5 profiles with prior-work records.

McKinsey
1
Airbnb
1
Bain
1
Amazon
1
Boston Consulting Group
1

Profiles cover recorded founders and leaders; contact details remain in Radar.

NEWS INTELLIGENCE

How this industry appears in the news

353,997 articles in the measured 12-month window.

Expand panel +
353,997articles in the measured year
74,387articles in 2026Q1
42.4%positive tone in the latest complete year

News volume trends

Life Sciences coverage across Italy · articles per complete quarter

044,24588,491132,736176,9822021Q2: 51,1562021Q22021Q3: 60,0272021Q4: 49,1502022Q1: 52,6622022Q2: 53,5022022Q22022Q3: 54,0332022Q4: 64,4432023Q1: 65,5482023Q2: 71,6102023Q22023Q3: 77,0222023Q4: 57,0952024Q1: 74,6432024Q2: 86,2162024Q22024Q3: 84,2872024Q4: 83,1652025Q1: 106,1412025Q2: 79,1332025Q22025Q3: 153,8972025Q4: 55,9132026Q1: 74,3872026Q1
View quarterly article counts
QuarterArticles
2021Q251,156
2021Q360,027
2021Q449,150
2022Q152,662
2022Q253,502
2022Q354,033
2022Q464,443
2023Q165,548
2023Q271,610
2023Q377,022
2023Q457,095
2024Q174,643
2024Q286,216
2024Q384,287
2024Q483,165
2025Q1106,141
2025Q279,133
2025Q3153,897
2025Q455,913
2026Q174,387

Article volume measures coverage, not market sales.

Tone of coverage over time

2021
88,779 positive · 32,040 neutral · 51,061 negative
2022
115,457 positive · 48,138 neutral · 60,525 negative
2023
145,587 positive · 61,321 neutral · 63,893 negative
2024
158,205 positive · 97,516 neutral · 72,024 negative
2025
167,226 positive · 152,009 neutral · 75,317 negative

Leading coverage topics

Life Sciences coverage across Italy · ranked by full-period article count.

Geopolitical Disputes And Contested Areas297,180 articles in the full recorded period
107,794 recent · 80,936 prior
International And Transnational Geographic Entities297,173 articles in the full recorded period
107,792 recent · 80,939 prior
Administrative And Political Subdivisions297,144 articles in the full recorded period
107,775 recent · 80,934 prior
International Sports Competitions35,832 articles in the full recorded period
9,528 recent · 8,369 prior
International Political Relations26,032 articles in the full recorded period
6,478 recent · 6,610 prior
Professional League Updates21,363 articles in the full recorded period
6,257 recent · 5,347 prior
Olympic Games Coverage19,056 articles in the full recorded period
6,161 recent · 5,063 prior
Championship Event Highlights15,853 articles in the full recorded period
4,391 recent · 3,477 prior
Security And Defense Policies15,120 articles in the full recorded period
4,530 recent · 4,043 prior
Athlete Transfer Rumors13,214 articles in the full recorded period
3,728 recent · 2,953 prior

Recent and prior counts use the source comparison windows.

Topics gaining and losing attention

Life Sciences coverage across Italy

KeywordRecentPriorChange
countries3,9071,435172%
olympic team selections1,7631,23643%
ski competitions997364174%
olympic venues81956146%
international cups67847144%
cannoli siciliani60339154%
solar electricity generation59838854%
ice sports58686581%
curling winter games527119343%
luge olympic sport509105385%
pope9471,769-46%
europa league3781,295-71%
tariff negotiations7191,213-41%
quarterfinals343778-56%
summer olympics athletics72730-90%

Event and signal lenses

Life Sciences coverage across Italy

All complete annual cohorts shown
Rising

Regulatory Risk

609,051 classified articles

territories, disputed islands, countries

15.3% critical · 12.3% positive
Rising

Funding Momentum

45,056 classified articles

club valuation, europa league, quarterfinals

32.2% critical · 42.2% positive
Rising

Growth

103,165 classified articles

gdp growth rate, gdp acceleration, economic output growth

24.2% critical · 47.1% positive

Life Sciences coverage across Italy. Topic labels describe recorded classifications and can include broad context.

RESEARCH SIGNALS

What Life Sciences research is working on

53,147 papers in the recorded worldwide scope.

Expand panel +
53,147papers
53,147worldwide comparison pool
—India-affiliated papers

Research orientation

Descriptive
21,347
Promising
16,144
Breakthrough
7,516
Problem-identifying
4,407
Cautionary
1,880
Comparative
1,302
Critical
551

Contribution mix

Empirical
25,959
Reviews
19,786
Methods-led
5,939
Position pieces
1,146
Theoretical
317

Tone counts: 42,568 positive · 8,415 neutral · 2,164 negative.

Common problems researchers identify
4,958 papers · 9.3% of this field
  • Agriculture506 papers
  • Antibiotic resistance341 papers
  • Production233 papers
  • Human health225 papers
  • Sustainability221 papers
  • Antimicrobial216 papers
  • Food safety192 papers
  • Food security181 papers

Landmark: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term prob

Cautions
1,880 papers · 3.5% of this field
  • Agriculture96 papers
  • Food safety80 papers
  • Gene66 papers
  • Antibiotic resistance61 papers
  • Toxicity56 papers
  • Population55 papers
  • Production52 papers
  • Human health51 papers

Landmark: Genomic responses in mouse models poorly mimic human inflammatory diseases

Opportunities
23,660 papers · 44.5% of this field
  • Gene1,464 papers
  • Agriculture827 papers
  • Fermentation719 papers
  • Antimicrobial639 papers
  • In vivo588 papers
  • Population535 papers
  • Transcriptome527 papers
  • Downregulation and upregulation520 papers

Landmark: Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Leading institutions

Harvard University
86,693
Howard Hughes Medical Institute
74,901
Chinese Academy of Sciences
61,376
Centre National de la Recherche Scientifique
49,087
Cornell University
42,772
Stanford University
38,500

Leading researchers

Ahmad Almilaji
14,302
Reiki Nishimura
13,204
Tomofumi Osako
13,204
Yasuyuki Nishiyama
13,204
Rumiko Tashima
13,204
Masahiro Nakano
13,204
Glenn R. Gibson
12,830
Gregor Reid
10,793

Highly cited breakthrough-labelled papers

  • Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity9,015 citations
  • In situ click chemistry generation of cyclooxygenase-2 inhibitors7,514 citations
  • U1 snRNP regulates cancer cell migration and invasion in vitro7,224 citations
  • Comprehensive molecular profiling of lung adenocarcinoma5,754 citations
  • Lanthanum Chloride Inhibits LPS Mediated Expressions of Pro-Inflammatory Cytokines and Adhesion Molecules in HUVECs: Involvement of NF-κB-Jmjd3 Signal5,748 citations

Common problems researchers identify

4,503 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Sustainable Biofuel and Biomass ProductionCommon problems researchers identify · 01

Sustainable Biofuel and Biomass Production

781 papers

17.3% of this theme group

Researchers discuss challenges in using microbes and plants for renewable fuels and biorefinery processes.

Biofuel (41) · Synthetic biology (53) · Biomass (45) · Biorefinery (28)

A review on the plant microbiome: Ecology, functions, and emerging trends in microbial application

Biofertilizers: An ecofriendly technology for nutrient recycling and environmental sustainability

View research history
YearShare index
202260.6
202359.3
202461.9
202567.0
Food Safety and Processing RisksCommon problems researchers identify · 02

Food Safety and Processing Risks

757 papers

16.8% of this theme group

Papers highlight microbial hazards and nutritional impacts linked to food manufacturing and consumer health.

Food safety (130) · Food processing (74) · Food products (50) · Human health (90)

Microbial Risks in Food: Evaluation of Implementation of Food Safety Measures

Nutritional quality and processing of plant proteins for healthy and sustainable foods

View research history
YearShare index
202270.2
202372.4
202477.4
202599.2
Gene Expression and mRNA TherapeuticsCommon problems researchers identify · 03

Gene Expression and mRNA Therapeutics

711 papers

15.8% of this theme group

Studies examine hurdles in controlling gene activity, mRNA delivery, and cell‑culture models for medicine.

Messenger RNA (28) · Gene (44) · Cell culture (23) · Gene expression (24)

Analysis of Cancer Metabolism by Imaging Hyperpolarized Nuclei: Prospects for Translation to Clinical Research

Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with

View research history
YearShare index
20222510.1
20232495.8
20242199.0
20251697.8
Crop Nutrition and Food SecurityCommon problems researchers identify · 04

Crop Nutrition and Food Security

693 papers

15.4% of this theme group

Research points to difficulties in improving nutrient uptake, breeding efficiency, and resilient agricultural systems.

Agriculture (208) · Crop (84) · Food security (86) · Germplasm (39)

Revisiting fertilisers and fertilisation strategies for improved nutrient uptake by plants

Breeding for nutrient use efficiency in crop plants: Mechanistic insights, genetic determinants, and emerging breeding technologies

View research history
YearShare index
20221635.2
20231667.4
20241799.9
20252026.9
Plant Disease Management and Pest ResistanceCommon problems researchers identify · 05

Plant Disease Management and Pest Resistance

691 papers

15.3% of this theme group

Works address obstacles in integrating pest control, host immunity, and pathogen evolution for healthier crops.

Fungicide (44) · Integrated pest management (54) · Host (41) · Disease management (32)

Innate Immunity in Plants: An Arms Race Between Pattern Recognition Receptors in Plants and Effectors in Microbial Pathogens

Insect-Borne Plant Pathogens and Their Vectors: Ecology, Evolution, and Complex Interactions

View research history
YearShare index
202227.8
202329.2
202427.8
202537.2
Antimicrobial Resistance Across SectorsCommon problems researchers identify · 06

Antimicrobial Resistance Across Sectors

447 papers

9.9% of this theme group

Literature flags the spread of drug‑resistant microbes in humans, livestock, and the environment.

Antibiotic resistance (301) · Antimicrobial (164) · Antibiotics (126) · Drug resistance (49)

Antimicrobial resistance in humans, livestock and the wider environment

Antimicrobial use and resistance

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Miscellaneous Biological and Chemical IssuesCommon problems researchers identify · 07

Miscellaneous Biological and Chemical Issues

423 papers

9.4% of this theme group

Papers cover diverse, less‑focused topics ranging from molecular order to interdisciplinary analyses.

Order (19) · NAD+ kinase (11) · Human being (12) · Sodium (11)

Modalidade, polaridade e legibilidade em resumos académicos: uma análise comparativa multidisciplinar

Obiteljska grupna konferencija: prilika za građansko pravosuđe?

View research history
YearShare index
202218.4
202321.9
202417.8
202512.5

Cautions

1,765 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Cellular Toxicity and Oxidative Stress AssaysCautions · 01

Cellular Toxicity and Oxidative Stress Assays

379 papers

21.5% of this theme group

Authors urge careful interpretation of in‑vitro and in‑vivo models measuring stress and viability.

In vivo (32) · Flow cytometry (16) · In vitro (27) · Oxidative stress (19)

Effects of Microplastics on Cell Viability, Phagocytic Activity and Oxidative Stress in Human Peripheral Blood Mononuclear Cells

Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes

View research history
YearShare index
20221034.9
20231110.3
2024911.7
2025818.5
Genomic Selection and Trait Prediction LimitsCautions · 02

Genomic Selection and Trait Prediction Limits

257 papers

14.6% of this theme group

Studies caution about uncertainties when applying genomic tools to plant breeding and animal feed strategies.

Agriculture (45) · Selection (26) · Production (28) · Trait (16)

Genomic selection in plant breeding: from theory to practice

Future Directions for Sustainable Poultry Feeding and Product Quality: Alternatives from Insects, Algae and Agro-Industrial Fermented By-Pro

View research history
YearShare index
20221437.3
20231478.4
20241637.4
20251817.4
Feed Additives and Health Impact UncertaintiesCautions · 03

Feed Additives and Health Impact Uncertainties

245 papers

13.9% of this theme group

Research highlights the need for rigorous evaluation of novel feed compounds on animal and human health.

Feed additive (27) · Animal feed (28) · Feed conversion ratio (32) · Health benefits (30)

Natural Bioactive Compounds as Feed Additives: Strategies for Sustainable and Functional Livestock Production

The impact of substituting animal with plant protein foods in adults’ self-selected diets on environmental, nutritional, and health outcomes

View research history
YearShare index
202222.2
202320.9
202417.3
202518.2
Food Contaminant Safety and RegulationCautions · 04

Food Contaminant Safety and Regulation

240 papers

13.6% of this theme group

Papers stress the importance of thorough safety assessments for emerging food additives and contaminants.

Food safety (66) · Hygiene (21) · Contamination (29) · Food contaminant (20)

Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters

Insect-derived food colorants: Chemistry, applications, safety, and regulatory perspectives

View research history
YearShare index
202291.3
202389.1
202495.4
2025105.8
DNA Damage and Repair Mechanism ComplexityCautions · 05

DNA Damage and Repair Mechanism Complexity

239 papers

13.5% of this theme group

Works point out challenges in interpreting gene‑expression changes linked to genomic instability.

Gene (41) · DNA damage (26) · DNA repair (13) · Gene expression (20)

Comparative analysis of microRNA expression in serum and plasma in patients screened for BRCA1 or BRCA2 mutations

Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer

View research history
YearShare index
20222415.6
20232417.4
20242125.5
20251613.8
Co‑Selection of Antimicrobial ResistanceCautions · 06

Co‑Selection of Antimicrobial Resistance

206 papers

11.7% of this theme group

Authors warn that biocides and metals can amplify antibiotic resistance in food‑borne pathogens.

Antibiotic resistance (59) · Antibiotics (47) · Antimicrobial (38) · Bacteria (26)

Antibiotic use in food animals worldwide, with a focus on Africa: Pluses and minuses

Co-Selection of Resistance to Antibiotics, Biocides and Heavy Metals, and Its Relevance to Foodborne Pathogens

View research history
YearShare index
2022886.3
2023838.0
2024911.9
2025963.5
Pesticide Resistance Management StrategiesCautions · 07

Pesticide Resistance Management Strategies

199 papers

11.3% of this theme group

Research advises caution when altering doses or using biological controls to avoid resistance buildup.

Pesticide (34) · Integrated pest management (21) · PEST analysis (30) · Biological pest control (20)

The use of fungal entomopathogens as endophytes in biological control: a review

Managing pesticide resistance by changing the applied dose: a modeling analysis incorporating pesticide persistence and including low-dose m

View research history
YearShare index
202266.9
202365.3
202466.9
202575.8

Opportunities

22,038 papers · 7 recurring themes
7 cards

Swipe or scroll horizontally to browse.

Advanced Antibody and Imaging TechniquesOpportunities · 01

Advanced Antibody and Imaging Techniques

1,044 papers

17.4% of this theme group

Opportunities arise from novel fluorescent antibodies and flow cytometry for in‑vivo diagnostics.

Antibody (70) · In vivo (81) · Fluorescence (40) · Flow cytometry (50)

Figure 4 from Ancestrally Diverse Autologous Patient-Derived Organoid–Immune Cell Coculture Platform for Addressing Immunotherapeutic Outcom

Preparation, Characterization, and Binding Mechanism of Nanobodies Targeting Multiple Serotypes of <i>Salmonella</i>

View research history
YearShare index
2022561.4
2023615.1
2024467.1
2025455.3
Gene Modulation for Disease TherapyOpportunities · 02

Gene Modulation for Disease Therapy

1,032 papers

17.2% of this theme group

Papers explore promising approaches using knockdown, up‑regulation, and apoptosis control to treat disorders.

Downregulation and upregulation (106) · Apoptosis (80) · Gene knockdown (103) · Cell growth (43)

Fat Mass and Obesity‐Associated Protein Contributes to Tumorigenesis and Drug Resistance of Diffuse Large B‐Cell Lymphoma by Suppressing <sc

RasGRP3 Promotes RAP1B Activity to Inhibit Endothelial Inflammation and Alleviate Atherosclerosis in High-Fat Diet-Fed ApoE−/− Mice

View research history
YearShare index
2022364.0
2023394.7
2024257.4
2025261.8
Functional Plant‑Based Foods and AntioxidantsOpportunities · 03

Functional Plant‑Based Foods and Antioxidants

878 papers

14.6% of this theme group

Research highlights the potential of bioactive ingredients to improve health and support sustainable diets.

Health benefits (78) · Functional food (61) · Ingredient (48) · Antioxidant (69)

Plant-based functional foods for healthy aging: current trends, bioactive compounds, and future perspectives

PLANT-BASED PROTEINS: SOURCES, EXTRACTION METHODS AND FUNCTIONAL PERSPECTIVES FOR THE SUSTAINABLE FOOD INDUSTRY

View research history
YearShare index
202226.7
202326.2
202427.1
202545.2
Epigenetic Editing and RNA‑Based DiagnosticsOpportunities · 04

Epigenetic Editing and RNA‑Based Diagnostics

823 papers

13.7% of this theme group

Studies reveal emerging tools for modifying DNA methylation and detecting disease‑related RNAs.

Gene (164) · DNA methylation (60) · Messenger RNA (76) · DNA damage (55)

Convergent DNA methylation abnormalities at enhancers and bivalent promoters in human growth disorders

Stimuli-ResponsiveFusion of Binary-Star IntelligentDNA System for the Signal-On Amplification Detection of Cancer-RelatedmiRNA

View research history
YearShare index
20222397.7
20232377.6
20242114.7
20251613.7
Novel Antimicrobials and Postbiotic ApplicationsOpportunities · 05

Novel Antimicrobials and Postbiotic Applications

809 papers

13.5% of this theme group

Works identify plant‑derived compounds and microbial metabolites as new strategies against resistant pathogens.

Antimicrobial (126) · Antibiotic resistance (66) · Biological pest control (54) · Bacteria (87)

Plants as sources of new antimicrobials and resistance-modifying agents

Postbiotics: Multifunctional Microbial Products Transforming Animal Health and Performance

View research history
YearShare index
2022524.8
2023510.4
2024554.5
2025649.8
Genetic Trait Mapping for Yield ImprovementOpportunities · 06

Genetic Trait Mapping for Yield Improvement

717 papers

11.9% of this theme group

Research focuses on leveraging germplasm and QTL analysis to boost crop productivity.

Germplasm (71) · Trait (52) · Quantitative trait locus (40) · Selection (53)

Evaluation of Genetic Variability and Trait Interrelationships Using Advanced Wheat Lines to Increase Yield

GENETIC VARIABILITY ANALYSIS FOR YIELD AND RELATED TRAITS IN WHEAT (TRITICUM AESTIVUM L.) MUTANT GENOTYPES

View research history
YearShare index
202253.0
202345.3
202439.2
202540.8
Sustainable Biomass Conversion and BioeconomyOpportunities · 07

Sustainable Biomass Conversion and Bioeconomy

697 papers

11.6% of this theme group

Papers present microbial fermentation and by‑product valorization as routes to greener agriculture.

Biomass (67) · Sustainability (77) · Agriculture (102) · Biofuel (35)

Microbial Fermentation: A Sustainable Strategy for Producing High-Value Bioactive Compounds for Agriculture, Animal Feed, and Human Health

Bioactive Compounds From Agri‐Food By‐Products: Advancements in Environmental Sustainability and Bioeconomic Progress

View research history
YearShare index
20221514.8
20231566.1
20241742.6
20251980.2

How this field compares with the research baseline

Orientation shares compared with 25,000 papers in the reference sample.

Research orientationThis fieldReference sample
Descriptive40.2%17.4%
Promising30.4%37.4%
Breakthrough14.1%26.2%
Problem-identifying8.3%9.8%
Cautionary3.5%4.4%
Comparative2.4%3.9%
Critical1.0%1.0%

Concerns receiving less research attention

Counts and shares refer to the stated research pool. A low count describes how much of that research is recorded here, not the absence of a real-world concern.

Concern / example paperPapersShareRaised as a problemWorldwide share
Privacy & surveillanceSARS-CoV-2 wastewater genomic surveillance: approaches, challenges, and opportunities870.21%25 (28.7%)0.21%
Hardware, e-waste & supply chainFate and Transport of Antibiotic Residues and Antibiotic Resistance Genes following Land Application of Manure Waste610.15%4 (6.6%)0.15%
Bias & fairnessGeographic Prevalence Heterogeneity Creates Unavoidable Fairness-Accuracy Trade-offs in Antimicrobial Resistance Predict120.03%2 (16.7%)0.03%
Safety & misusePublic perceptions and information sources on genetically modified organisms in Kenya30.01%3 (100.0%)0.01%
Energy & datacenter footprintIntegration of GWAS and WGCNA Identifies PUE‐Related Gene <i>TaERF112</i> in Wheat10.0%0 (0.0%)0.0%
Water use00.0%0 (%)0.0%
Carbon & emissions of compute00.0%0 (%)0.0%
Labour & data work00.0%0 (%)0.0%
Concentration of compute power00.0%0 (%)0.0%

Research orientation and citation rankings describe the covered collection. Its recorded publication dates do not support an overall publication-volume trend.

Institution and researcher rankings use citations to their covered work. Research scope: worldwide. This may be broader than the company geography.

INNOVATION SIGNALS

Who files Life Sciences patents in Italy

Published patent filings in the recorded source window.

Expand panel +
8,235filings 2016–2025
6,256assignees
938peak annual filings

Filing momentum

02705398091,0792016: 75620162017: 8202018: 78420182019: 8972020: 83520202021: 9382022: 78120222023: 8722024: 80220242025: 7502025

Who files the most

Novartis Vaccines & Diagnostic
655
Ospedale SAN Raffaele SRL
648
Philogen SPA
535
FOND Telethon
483
Consiglio Nazionale Ricerche
399
Angeletti P IST Richerche BIO
313
Sigma TAU IND Farmaceuti
307
Versalis SPA
261
GEOGRAPHIC FOOTPRINT

Where companies are based

Company counts, hiring and disclosed funding across the recorded hubs.

Expand panel +
8 cards

Swipe or scroll horizontally to browse.

UNDERSTAND THE LANDSCAPE

Life Sciences in Italy: key questions

Clear definitions for making better comparisons.

What does this landscape measure?

It measures the tracked company ecosystem, recorded funding, hiring and other available evidence. It is not a market-size estimate.

Can segment counts be added together?

No. A company can belong to several segments, so segment counts and funding can overlap.

What does a missing figure mean?

A dash or unavailable panel means the current reviewed source snapshot does not support that figure.

Company ecosystem snapshot: 1 September 2026. Funding is recorded in USD; filed accounts retain their stated currency and reporting basis. Each section identifies its own coverage. The news and research behind these sections is explorable in Prism.

Canonical landscape ↗
Coming soon